Hyperintense Putaminal Rim Sign Is Not a Hallmark of Multiple System Atrophy at 3T

References

1. ↵
   Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002;125:1070–1083

   Abstract/FREE Full Text
2. ↵
   Quinn N, Marsden CD, Fahn S, ed. Multiple system atrophy: movement disorder. Oxford: Butterworth–Heinemann1994;262–281
3. ↵
   Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 1992;42:1142–1146

   Abstract/FREE Full Text
4. ↵
   Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997;54:937–944

   CrossRefPubMedWeb of Science
5. ↵
   Wenning GK, Tison F, Ben-Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133–147

   CrossRefPubMedWeb of Science
6. ↵
   Savoiardo M, Strada L, Girotti F, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990;174:693–696

   PubMedWeb of Science
7. ↵
   Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65–71

   Abstract/FREE Full Text
8. ↵
   Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical Parkinsonian syndromes with routine MRI. Neurology 2000;54:697–702

   Abstract/FREE Full Text
9. ↵
   Kraft E, Schwarz J, Trenkwalder C, et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 1999;56:225–228

   CrossRefPubMedWeb of Science
10. ↵
    Lee EA, Cho HI, Kim SS, Lee WY. Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 2004;10:363–368

    CrossRefPubMed
11. ↵
    Macia F, Yekhlef F, Ballan G, et al. T2-hyperintense lateral rim and hypointense putamen are typical but not exclusive of multiple system atrophy. Arch Neurol 2001;58:1024–1026

    CrossRefPubMedWeb of Science
12. ↵
    Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiple system atrophy and Parkinson disease. Arch Neurol 2002;59:835–842

    CrossRefPubMedWeb of Science
13. ↵
    Watanabe H, Fukatsu H, Hishikawa N, et al. Field strengths and sequences influence putaminal MRI findings in multiple system atrophy. Neurology 2004;62:671

    FREE Full Text
14. ↵
    Hashemi RH, Bradley WG Jr, Lisanti CJ. MRI: the basics. 2nd ed. Philadelphia: Lippincott Williams & Wilkins2004;190–199
15. ↵
    Schwarz J, Weis S, Kraft E, et al. Signal changes on MRI and increase of reactive micro-astrogliosis and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996;60:98–101

    Abstract/FREE Full Text
16. ↵
    Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994;57:129–133

    FREE Full Text
17. ↵
    Konayaga M, Sakai M, Matsuoka Y, et al. Pathological correlate of the slitlike changes on MRI at the putaminal margin in multiple system atrophy. J Neurol 1999;246:142–143

    CrossRefPubMedWeb of Science
18. ↵
    Block SA, Bakshi R, FLAIR MRI of striatonigral degeneration. Neurology 2001;56:1200

    FREE Full Text
19. ↵
    Raz N, Rodrigue KM, Kennedy KM, et al. Differential aging of the human striatum: longitudinal evidence. AJNR Am J Neuroradiol 2003;24:1849–1856

    Abstract/FREE Full Text
20. ↵
    Frayne R, Goodyear BG, Dickhoff P, et al. Magnetic resonance imaging at 3.0 tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 2003;38:385–402

    CrossRefPubMed